20. January 2019

Reniale®: Development of the Biomarker assays well advanced

A key element in improving Reniale® is to demonstrate the biological effectiveness of Reniale®. Here, various biomarker assays are used, which identify and quantify the substances involved in the mechanism of action. In collaboration with Prof. Stefan Wittke, member of the Scientific Advisory Board of Vaccentis AG, appropriate test systems could successfully be established. The essential “proof of concept” is thus provided. The next step is to confirm these test systems using human tumors and Reniale® preparations.